CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义

doi:10.3969/j.issn.1000-8535.2022.01.012

广州医药 ›› 2022, Vol. 53 ›› Issue (1): 58-61.DOI: 10.3969/j.issn.1000-8535.2022.01.012

CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义

郭小芳¹, 王凌云², 吕天宝¹

1 新乡市第二人民医院介入放射科(新乡 453000)
2 新乡市第四人民医院 CT室(新乡 453000)

收稿日期:2021-04-13 出版日期:2022-01-20 发布日期:2022-04-12

Clinical significance of CT combined with MRI scans in diagnosis of primary liver cancer and prognosis evaluation after interventional therapy

GUO Xiaofang¹, WANG Lingyun², LV Tianbao¹

1 Department of Interventional Radiology, The Second People's Hospital of Xinxiang City, Xinxiang 453000,China
2 CT Room of The Fourth People's Hospital of Xinxiang City, Xinxiang 453000, China

Received:2021-04-13 Online:2022-01-20 Published:2022-04-12

摘要/Abstract

摘要： 目的分析CT+MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义。方法选定本院2019年1月—2021年1月住院治疗的150例原发性肝癌患者,入院后均接受介入治疗,分别予以CT、MRI检查,将手术病理检查结果作为本次研究的金标准,比较CT、MRI、CT+MRI诊断效能,Kappa检验CT、MRI、CT+MRI与金标准的一致性,比较CT、MRI、CT+MRI介入术后病灶检出率。结果 CT+MRI诊断准确率(98.67%)、特异度(75.00%)、灵敏度(99.32%)均高于CT(86.00%、25.00%、87.67%)、MRI(90.67%、91.78%、50.00%),P＜0.05(差异均有统计学意义),CT+MRI与金标准的一致性较好(Kappa值为0.779),CT、MRI与金标准的一致性一般(Kappa值为0.527、0.596)。CT+MRI介入术后病灶总检出率(12.00%)高于CT(2.00%)、MRI(4.00%),P＜0.05(差异有统计学意义)。结论 CT+MRI可提高原发性肝癌患者介入术后病灶检出率,弥补了单一CT、MRI检查的不足。

关键词: CT, MRI, 原发性肝癌, 介入治疗

Abstract: Objective To evaluate the clinical significance of CT + MRI scans in diagnosis of primary liver cancer and prognosis evaluation after interventional therapy. Methods A total of 150 cases of patients with primary liver cancer admitted to our hospital from January 2019 to January 2021 were selected. They all received interventional treatment, and were examined by CT and MRI. The results of pathological examination were taken as the gold standard in this study to compare the diagnostic efficacy of CT, MRI and CT+MRI.Kappa value was used to compare the consistency of CT, MRI, CT+MRI scans with gold standard, and compared the detection rate of lesions after CT, MRI and CT+MRI interventional surgery. Results The diagnostic accuracy (98.67%), specificity (75.00%) and sensitivity (99.32%) of CT + MRI scans were higher than those of CT (86.00%, 25.00%, 87.67%) and MRI scans (90.67%, 91.78%, 50.00%),P<0.05 (which differences were statistically significant). The consistency of CT + MRI scans with gold standard was good (kappa value was 0.779), but the consistency of CT/MRI scans with gold standard were not satisfying (kappa value were 0.527, 0.596). The total detection rate of lesions after CT + MRI interventional surgery (12.00%) was higher than that of CT (2.00%) and MRI (4.00%, which P<0.05). Conclusion CT + MRI scans can improve the detection rate of lesions in patients with primary liver cancer after interventional therapy, and make up for the deficiency of only CT or MRI scans.

Key words: CT, MRI, primary liver cancer, interventional therapy

郭小芳, 王凌云, 吕天宝. CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义[J]. 广州医药, 2022, 53(1): 58-61.

GUO Xiaofang, WANG Lingyun, LV Tianbao. Clinical significance of CT combined with MRI scans in diagnosis of primary liver cancer and prognosis evaluation after interventional therapy[J]. Guangzhou Medical Journal, 2022, 53(1): 58-61.

参考文献

[1] 刘小玲,阮君,朱敬松. MRI与CT在原发性肝癌介入治疗术后残余复发的应用分析[J]. 医学影像学杂志,2020,30(11):2135-2138.
[2] 陈勇. CT扫描联合磁共振诊断原发性肝癌及评估其介入治疗术后的临床效果评价[J]. 中国医疗器械信息,2018,24(9):67-68.
[3] 周占文. CT扫描联合磁共振诊断原发性肝癌及评估其介入治疗术后的临床效果[J]. 胃肠病学和肝病学杂志,2017,26(8):926-929.
[4] MORI A, ARIMOTO A, HAMAGUCHI Y, et al. Risk factors and outcome of portal vein thrombosis after laparoscopic and open hepatectomy for primary liver cancer: a single-center experience[J]. World J Surg, 2020, 44(9):3093-3099.
[5] 向森,杨光华,张开芳,等. CT增强扫描与MRI在诊断原发性肝癌患者中临床价值[J]. 中国CT和MRI杂志,2017,15(7):88-90.
[6] 齐杰,高战强,刘术昌,等. 磁共振扩散加权成像与螺旋CT分别联合血清AFP对早期原发性肝癌诊断价值的对比分析[J]. 实用癌症杂志,2019,34(2):285-288.
[7] 中华预防医学会肝胆胰疾病预防与控制专业委员会,中国研究型医院学会肝病专业委员会,中华医学会肝病学分会,等. 原发性肝癌的分层筛查与监测指南(2020版)[J]. 临床肝胆病杂志,2021,37(2):286-295.
[8] 刘帅,许亚飞. CT扫描联合MRI在原发性肝癌的诊断及介入治疗术后的评价应用[J]. 浙江创伤外科,2019,24(2):411-412.
[9] 杨青松. CT扫描联合磁共振诊断原发性肝癌及评估其介入治疗术后的临床效果评价[J]. 当代医学,2019,25(30):110-112.
[10] 朱鸷翔,沈松鹤,李荟苹,等. CT与磁共振成像对原发性肝癌患者经导管肝动脉化疗栓塞术后复查诊断准确率的对比研究[J]. 实用医学影像杂志,2019,20(5):522-524.
[11] AKINYEMIJU T, ABERA S, AHMED M M, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015[J]. JAMA Oncol, 2017, 3(12):1683-1691.
[12] 张丽,张强,董光. ROC曲线评价DWI对原发性肝细胞癌RFA术后早期复发病灶的诊断价值[J]. 潍坊医学院学报,2017,39(6):446-448.
[13] 樊建朝,赵香田. 核磁共振、增强CT及超声造影对肝癌介入治疗疗效评估的对比研究[J]. 中西医结合肝病杂志,2019,29(5):463-465.
[14] 郑新闻,刘丹,李振平,等. 3.0T MRI与64排CT评价原发性肝癌介入治疗后疗效的价值[J]. 中国CT和MRI杂志,2019,17(2):32-34,56.
[15] 齐杰,高战强,刘树昌,等. 磁共振扩散加权成像联合血清肿瘤标志物对诊断早期原发性肝癌价值分析[J]. 临床军医杂志,2018,46(9):1057-1058.

CT扫描结合MRI在原发性肝癌诊断与介入治疗预后评估中的临床意义

Clinical significance of CT combined with MRI scans in diagnosis of primary liver cancer and prognosis evaluation after interventional therapy

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	崔中伟. MRI检查对颈椎病患者椎间盘及颈髓病变检出率的影响[J]. 广州医药, 2022, 53(1): 54-57.
[2]	李新. CT混合征和岛征预测脑出血早期血肿扩大的临床价值[J]. 广州医药, 2022, 53(1): 121-124.
[3]	孙瑞辉. 分析比较胆囊癌与非胆囊癌的CT图象[J]. 广州医药, 2022, 53(1): 125-128.
[4]	朱清红, 陈小君, 甘庆权. 千伏锥形束CT(kV-CBCT)图像引导宫颈癌放射治疗的三维摆位误差分析[J]. 广州医药, 2021, 52(5): 113-116.
[5]	区文财, 何尚鹏, 梁宇翔, 邱春花. mpMRI-TRUS认知融合技术在前列腺靶向穿刺的应用研究[J]. 广州医药, 2021, 52(4): 77-79.
[6]	李月菊. HPV联合TCT检测对宫颈病变诊断的预测价值[J]. 广州医药, 2021, 52(3): 48-51.
[7]	张棪, 张念如. 颅内出血在磁敏感成像及CT成像的影像价值[J]. 广州医药, 2021, 52(3): 123-126.
[8]	叶莉华, 沈秀英. 品管圈在降低造影剂外渗中的运用[J]. 广州医药, 2020, 51(6): 113-116.
[9]	郑标林, 刘雪燕. 不同BMI组危重患者能量需求的 Harris-Benedict 公式估算法[J]. 广州医药, 2020, 51(4): 51-54.
[10]	蔡莹翔. 探讨B超与MRI、宫腔镜联合诊断对宫腔占位性病变的临床意义[J]. 广州医药, 2020, 51(4): 68-70.
[11]	李晓岩, 艾菊, 耿成亮, 刘明琦. 毕节地区新型冠状病毒肺炎胸部CT影像学特征[J]. 广州医药, 2020, 51(4): 75-79.
[12]	林晓纯, 林坤鹏, 林纯旋. 贝伐单抗联合肝动脉化疗栓塞治疗原发性肝癌的 Meta分析[J]. 广州医药, 2020, 51(3): 86-92.
[13]	刘霞, 方喜生, 翁成荫, 伍勇, 毛海波, 李宝秀, 王丽娜, 刘国龙. 原发性肝癌患者循环肿瘤细胞检测及其与术后复发转移的关系[J]. 广州医药, 2020, 51(2): 36-39.
[14]	关则想, 李红, 白婷, 麦益友. 喘憋性肺炎合并患儿血清PCT、CRP水平观察[J]. 广州医药, 2020, 51(2): 106-109.
[15]	沈玲, 杨秀丽, 亚国伟, 胡孟达. 小剂量阿帕替尼联合TACE治疗晚期肝癌临床观察[J]. 广州医药, 2019, 50(2): 72-75.